Roc vs. Sux - The CURASMUR Trial

February 18, 2020 00:19:11
Roc vs. Sux - The CURASMUR Trial
Critical Care Perspectives in Emergency Medicine
Roc vs. Sux - The CURASMUR Trial

Feb 18 2020 | 00:19:11

/

Show Notes

The debate on the ideal neuromuscular blocking agent for RSI in emergency intubations rages on. In this podcast, we review the latest randomized trial comparing rocuronium with succinylcholine in out-of-hospital patients needing emergency tracheal intubation – The CURASMUR Trial. Emergency medicine airway guru Dr. Ken Butler takes us through the paper and provides his expert opinion on which NMBA you should be reaching for in your next intubation!

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

December 13, 2022 00:24:33
Episode Cover

Double Sequential External Defibrillation for Refractory Ventricular Fibrillation

More than 350,000 cardiac arrests occur each year in North America.  Approximately 100,000 of these arrests are due to shockable rhythms.  Unfortunately, many patients...

Listen

Episode 0

July 07, 2023 00:28:56
Episode Cover

VL versus DL...And The Winner Is?

Over 1 million critically ill patients undergo intubation each year in the United States.  Though direct laryngoscopy remains the most common technique worldwide for...

Listen

Episode

March 09, 2018 00:21:48
Episode Cover

Post-Arrest Ventilator Management

In this episode, we review the critical pearls and pitfalls in ventilating the post cardiac arrest patient.  Are lung protective strategies useful? What is...

Listen